Borgeson Blake 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Borgeson Blake（CIK 1856094）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-10-07）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-07 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 50,000 | $242,000 |
| 2026-09-02 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 30,000 | $100,200 |
| 2026-08-06 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 30,000 | $97,500 |
| 2026-07-09 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 40,000 | $158,500 |
| 2026-06-22 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 88,424 | $0 |
| 2026-06-04 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 30,000 | $110,400 |
| 2026-05-07 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 30,000 | $105,600 |
| 2026-04-08 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 30,000 | $93,000 |
| 2026-03-04 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 170,000 | $588,200 |
| 2026-02-06 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 220,000 | $924,000 |
| 2026-01-08 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 220,000 | $959,200 |
| 2025-12-04 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 卖出 | 220,000 | $961,400 |
| 2025-06-23 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 22,016 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-07